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SUMO-Targeted Ubiquitin Ligases
(STUbLs) Reduce the Toxicity and
Abnormal Transcriptional Activity
Associated With a Mutant,
Aggregation-Prone Fragment of
Huntingtin
Kentaro Ohkuni1†, Nagesh Pasupala2†‡, Jennifer Peek2, Grace Lauren Holloway2,
Gloria D. Sclar2, Reuben Levy-Myers2, Richard E. Baker3, Munira A. Basrai1 and
Oliver Kerscher2*
1 Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD,
United States, 2 Biology Department, College of William & Mary, Williamsburg, VA, United States, 3 Department of
Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, MA, United States
Cell viability and gene expression profiles are altered in cellular models of
neurodegenerative disorders such as Huntington’s Disease (HD). Using the yeast model
system, we show that the SUMO-targeted ubiquitin ligase (STUbL) Slx5 reduces the
toxicity and abnormal transcriptional activity associated with a mutant, aggregation-
prone fragment of huntingtin (Htt), the causative agent of HD. We demonstrate that
expression of an aggregation-prone Htt construct with 103 glutamine residues (103Q),
but not the non-expanded form (25Q), results in severe growth defects in slx51 and
slx81 cells. Since Slx5 is a nuclear protein and because Htt expression affects gene
transcription, we assessed the effect of STUbLs on the transcriptional properties of
aggregation-prone Htt. Expression of Htt 25Q and 55Q fused to the Gal4 activation
domain (AD) resulted in reporter gene auto-activation. Remarkably, the auto-activation
of Htt constructs was abolished by expression of Slx5 fused to the Gal4 DNA-binding
domain (BD-Slx5). In support of these observations, RNF4, the human ortholog of
Slx5, curbs the aberrant transcriptional activity of aggregation-prone Htt in yeast and
a variety of cultured human cell lines. Functionally, we find that an extra copy of SLX5
specifically reduces Htt aggregates in the cytosol as well as chromatin-associated Htt
aggregates in the nucleus. Finally, using RNA sequencing, we identified and confirmed
specific targets of Htt’s transcriptional activity that are modulated by Slx5. In summary,
this study of STUbLs uncovers a conserved pathway that counteracts the accumulation
of aggregating, transcriptionally active Htt (and possibly other poly-glutamine expanded
proteins) on chromatin in both yeast and in mammalian cells.
Keywords: Slx5, STUbL, SUMO, ubiquitin, Htt
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INTRODUCTION
Ubiquitin and SUMO are members of a conserved family of small
ubiquitin-like modifier proteins (UBLs) that can be conjugated
to lysine residues of target proteins to modulate their activity,
function, localization, and half-life. The conjugation of both
SUMO and ubiquitin to numerous target proteins is a multi-
step process and involves a cascade of similar, yet distinct E1
activating enzymes, E2 conjugating enzymes, and E3 ligases.
Additionally, dedicated SUMO or ubiquitin-specific proteases
render these protein modifiers conjugation competent and also
aid in their deconjugation from modified proteins. As such,
the dynamic conjugation and deconjugation of UBLs has key
roles in cell growth and the maintenance of genome integrity
and has been implicated in disease-related processes including
cancer, inflammation, and neurodegeneration (Hoeller et al.,
2006; Kerscher et al., 2006; Dorval and Fraser, 2007; Dasso,
2008; Liu and Shuai, 2008; Sarge and Park-Sarge, 2009; van Wijk
et al., 2011; Cubeñas-Potts and Matunis, 2013). Mammalian cells
express one form of ubiquitin and three forms of conjugatable
SUMO (SUMO-1, SUMO-2, and SUMO-3), while budding yeast
only expresses one form each of ubiquitin and SUMO (Smt3).
Chains of ubiquitin can be formed through conjugation of
internal lysines. Analogously, Smt3, SUMO-2, and SUMO-3 can
form SUMO chains on the proteins they modify, a property not
shared by SUMO-1, which lacks the internal lysines required for
polymerization (Ulrich, 2008; Vertegaal, 2010). The majority of
proteins that are modified with ubiquitin chains are targeted to
the proteasome. In contrast, SUMO chains and hybrid SUMO-
ubiquitin chains do not play a direct role in proteolytic targeting
but play an important but poorly understood role in SUMO-
dependent signaling and the regulation of chromatin (Guzzo
et al., 2012).
STUbLs, including the heterodimeric Slx5/Slx8 in budding
yeast and the RNF4 homodimer in mammalian cells, are
ubiquitin E3 ligases that can specifically target and bind
sumoylated proteins and facilitate their ubiquitylation. Members
of this unusual subfamily of ubiquitin ligases are well conserved,
contain a RING domain required for their ubiquitylation activity,
and use multiple SIMs (SUMO-interacting motifs) to target
sumoylated substrates (Wang et al., 2006; Kerscher, 2007; Sun
et al., 2007; Uzunova et al., 2007; Xie et al., 2007; Mullen
and Brill, 2008; Tatham et al., 2008; Prudden et al., 2011;
Alonso et al., 2012). Not surprisingly, STUbLs play an important
role in the cross-regulation of proteins that can be modified
with both SUMO and ubiquitin (Perry et al., 2008; Geoffroy
and Hay, 2009). Deletion of SLX5 and SLX8 results in the
accumulation of high-molecular weight SUMO adducts and
renders cells hypersensitive to DNA damage and perturbed
DNA replication (Zhang et al., 2006; Prudden et al., 2007).
Similarly, depletion of RNF4 sensitizes cells to DNA damage
(Tatham et al., 2008; Geoffroy and Hay, 2009; Yin et al., 2012).
However, several lines of evidence suggest that STUbLs also
play a critical role in protein quality control. For example,
Slx5/Slx8 plays a role in degrading a mutant yeast transcriptional
regulator, mot1-103, the nuclear degradation of the SUMO E3
ligase Siz1 in mitosis, and proteolysis of centromeric histone
H3 variant Cse4, and also a transcription factor, Mat α2, that is
not modified with SUMO (Wang and Prelich, 2009; Westerbeck
et al., 2014; Hickey and Hochstrasser, 2015; Ohkuni et al., 2016).
Similarly, RNF4 has been shown to regulate the SUMO- and
ubiquitin-mediated proteasomal degradation of a mutant cystic
fibrosis transmembrane conductance regulator (F508del CFTR),
mutant attaxin (Atxn1 82Q), and possibly the reduction of SDS-
resistant aggregates of mutant huntingtin (Htt, 97QP) in the
cytosol of mammalian cells (Ahner et al., 2013; Guo et al.,
2014).
Mutant Htt is the causative agent of Huntington’s disease
(HD), a hereditary neurodegenerative illness that affects 2.71
per 100,000 people worldwide (Pringsheim et al., 2012). The
IT15 gene, first discovered in 1993, encodes the huntingtin
protein (Htt) which is essential for normal development of
mammals and interacts with a variety of proteins implicated
in transcription, intracellular transport, and cell signaling.
However, the complete extent of Htt function remains unknown
(Cattaneo et al., 2005). The amino-terminus of Htt normally
contains a stretch of 17–28 glutamine (Q) residues, that
is expanded to more than 36Q (and sometimes over 100)
in patients with HD. These amino-terminal poly-glutamine
expansions form aggregates of mutant Htt that visibly accumulate
in neurons and in cell culture models, including budding
yeast.
It has been suggested that Htt aggregates may be
neuroprotective in that they incorporate cytotoxic Htt monomers
into inert cellular inclusions (Arrasate et al., 2004). However,
there is also ample evidence that cellular aggregates of Htt
sequester a variety of other proteins required for vesicle
trafficking, cell cycle regulation, transcriptional regulation,
cytoskeletal functions, cell signaling, and protein turnover,
thus contributing to the demise of cells expressing these
aggregation-prone proteins (Suhr et al., 2001; Bauer et al., 2012).
The majority of Htt aggregates occur in the cytosol, but there
is considerable evidence that the accumulation of Htt in the
nucleus enhances its toxicity [reviewed in Davies et al. (1997),
Lunkes and Mandel (1997), and Benn et al. (2008)]. For example,
it has recently been found that a poly-glutamine expanded Htt
protein fused with a nuclear localization signal (Htt-103Q-NLS),
unlike Htt-103Q, is highly toxic to Wild-type (WT) budding
yeast (Wolfe et al., 2014). Interestingly, the authors of this
study found that toxicity of Htt-103Q-NLS can be suppressed by
overexpression of other poly-Q rich proteins including Nab3, an
RNA binding protein (Wolfe et al., 2014). The poly-Q tract on
Htt is known to sequester other naturally occurring proteins with
poly-Q tracts. For example, there are 14 proteins with poly-Q
tracts of at least 20 glutamines encoded in the yeast genome, and
at least 66 genes in the human genome that have been classified
as encoding poly-Q proteins (Butland et al., 2007). Proteins with
poly-Q tracts are involved in a variety of functions, but the
majority are classified as transcription cofactors, coactivators,
and DNA-binding proteins, or regulators of metabolic processes
(Butland et al., 2007). In mammalian cells, poly-Q expanded
Htt globally disrupts transcriptional regulation (Steffan et al.,
2000; Dunah et al., 2002; Schaffar et al., 2015). In a yeast
two-hybrid assay, transcriptional activity of aggregation-prone
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Htt was dependent on the length of the poly-Q tract (Gerber
et al., 1994; Benn et al., 2008; Atanesyan et al., 2012). These
observations underscore the importance of understanding the
functional role that Htt has in the nucleus.
We reasoned that Slx5, owing to it’s protein quality-control
functions, may alter the aggregation or distribution of Htt
aggregates in WT cells. Therefore, we investigated whether
STUbLs, Slx5, and Slx8 play a role in preventing the toxicity
of poly-Q expanded Htt in budding yeast cells. We found that
expression of Htt-103Q elicited a severe growth defect and was
toxic in slx51 and slx81 mutants. The genetic interaction of Htt
with STUbLs led us to examine the functional role of STUbLs
in counteracting the toxic effects of Htt-103Q. For this we
assessed the interaction of STUbLs with various Htt constructs
using a reporter gene assay. Using this assay, we established
that both Slx5 and RNF4, the human STUbL ortholog, reduced
the transcriptional activity of Htt in yeast and human cells.
Functionally, we determined that a plasmid-borne copy of SLX5
reduced the levels of both cytosolic and nuclear Htt aggregates
but did not affect the levels of monomeric Htt protein in the
nucleus. Finally, we completed a global RNA sequencing study to
identify transcripts that are affected by Htt-103Q and modulated
by an extra copy of SLX5. Therefore, our data implicates STUbLs
in a conserved mechanism that prevents the accumulation
of aggregating proteins such as Htt on chromatin and curbs
their promiscuous transcriptional activity both in yeast and in
mammalian cells.
MATERIALS AND METHODS
Yeast Strains, Plasmids, Mammalian
Tissue Culture, and Media
All strains and plasmids used in this study are listed in
Supplementary Table S1. Unless noted otherwise, preparation
of yeast media and manipulation of yeast strains were performed
as previously reported (Guthrie and Fink, 2002). Unless
otherwise noted, all yeast strains were grown at 30◦C. Yeast
plasmids expressing 25Q and 103Q Htt were purchased
from Addgene.org (Addgene plasmid # 1177 (GPD-25Q-
GFP Htt in p416), # 1180 (GPD-103Q-GFP Htt in p416)).
These plasmids were used for growth assays and microscopy.
For Htt localization and auto-activation assays, Htt with
25Q, 55Q, and 97Q were PCR-amplified using NEB Q5
hot start high-fidelity polymerase 2× master mix (Cat
# M0494S) and cloned into the pCR8/GW/TOPO entry
vector (Life Technologies) and then recombined into either
pAG414GAL-ccdB-DsRed (Addgene #14359) forming GAL-
97QHtt-DsRed/TRP1/CEN (BOK 1213) or pACT2.2gtwy
(Addgene # 11346) forming ADH1-GAL4AD-25QHtt/LEU2/2µ
(BOK 1207), ADH1-GAL4AD-55QHtt/LEU2/2µ (BOK1209)
and ADH1-GAL4AD-97QHtt/LEU2/2µ (BOK 1215). All
plasmids expressing Htt encode exon I (17 amino acids) followed
by poly-Q and proline-rich regions. NEBase Changer v1.2.1
software at NEB website was used for designing mutagenesis
5′-phospho primers and NEB Q5 hot start high-fidelity
polymerase 2x master mix was used for PCR amplification.
After PCR, template plasmid DNA in the reaction mixture
was digested by treatment with DpnI enzyme (cat # R0176S)
and PCR amplicon was ligated using T4 DNA Ligase enzyme
(Cat # M0202S). All primer sequences used for cloning and
mutagenesis are available upon request. Yeast cells were
transformed as previously described (Amberg et al., 2005)
or using the frozen-EZ yeast transformation II kit (Zymo
research corporation, Irvine CA). For mammalian 2-hybrid
assays, the Matchmaker Mammalian Assay Kit 2 (Clontech.com
Cat. No. 630305) was used as per suppliers instructions.
The pVP16 Activation Domain (AD) Htt constructs were
designed in the Kerscher lab and synthesized by Genewiz (South
Plainville, NJ, United States) to produce pVP16-Htt25Q-AD
and pVP16-Htt55Q-AD. RNF4 was PCR amplified and cloned
into EcoR1 and HindIII sites in the pM-BD plasmid to produce
pM-BD-RNF4.
PC3 (Prostate Adenocarcinoma), PNT2 (Prostate
Epithelium), and LNCaP (Prostate Carcinoma) cells were
grown in RPMI media with 10% heat inactivated FBS (Thermo
Fisher Scientific #10438018) and 1% antifungal/antibiotic
(anti/anti) (Thermo Fisher Scientific #15240062). PC12
(Rat pheochromocytoma) cells were grown as above but
also contained 10% horse serum. HEK 293 (Embryonic
Kidney) cells were grown in DMEM media with 10% heat
inactivated FBS and 1% anti-anti. Cells were transfected
using Lipofectamine 2000 or 3000 reagents using supplier
instruction (Thermo Fisher Scientific, Cat. No. 11668-019 or
L3000-015).
Growth Curves
Yeast strains YOK2206-2207, YOK2209-2210, YOK2824-2828
were grown overnight in 5 ml selective media with 2% dextrose.
OD readings were recorded every hour from OD600 ∼ 0.15
to OD600 ∼2.0 for up to 10 h (Thermo Fisher Scientific
Spectronic 200). Readings were averaged and graphed in
Microsoft Excel. Error bars represent the standard error of four
independent cultures for each strain listed. Doubling times were
calculated as previously published (Murakami and Kaeberlein,
2009).
Spotting Assays
Yeast strains were grown overnight in 5 ml selective media with
2% dextrose. When cultures reached mid-log phase (OD600 0.8–
1.0), 1 OD of cells was harvested. Cultures were 10-fold serially
diluted and 5 µl was spotted onto selective medium containing
2% dextrose. Plates were dried at ambient temperature and
incubated at 30◦C for up to 3 days.
Ortho-Nitrophenyl-β-Galactoside (ONPG)
and SEAP Assays
Yeast cultures of pJ694alpha containing the appropriate AD
and BD constructs were grown until cells reached mid-log
phase (OD600 of 1 ml = 0.5–0.8) and lac-Z reporter gene
expression was determined as outlined in the Clontech Yeast
Methods protocols handbook (PT3024-1). Briefly, the exact
OD600 was recorded when the cultures were harvested. Cells
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were then washed in Z-buffer (16.1 g/L of Na2HPO4·7H2O,
5.50 g/L of NaH2PO4·H2O, 0.75 g/L of KCl, and 0.246 g/L
of MgSO4·7H2O. pH 7.0). Cell pellets were resuspended in
100 µl of Z-buffer and three cycles of freeze/thaw each for 30 s
was done to break open the cells. Cells were then incubated
in the presence of ONPG (4 mg/ml) in Z-buffer at 30◦C
until yellow color developed. Reactions were stopped using
1 M Na2CO3 and cell debris was removed by centrifugation.
The OD420 was determined using a spectrophotometer and
β-galactosidase units were calculated using the formula [β-gal
units = 1000 × OD420/(t × V ×OD600)] where t is elapsed time
(in minutes) of incubation, V is 0.1 ml times 5 (concentration
factor) (Miller, 1972). The β-galactosidase units reported were
average values of at least three independent experiments and
values were graphed including +/−SD. The Great EscAPe
Chemiluminescence kit (Clontech #631737) was used to detect
SEAP levels in the mammalian 2-hybrid assay. Twenty-five
microliters of culture media were obtained and spun for
1 min at 12,000 rpm to remove cells. The supernatant was
transferred to black 96-well plates with clear, flat well bottoms
(Corning #353219) and after addition of SEAP substrate solution,
Chemiluminescent signals were visualized and analyzed using
a Li-COR C-Digit Blot Scanner and also autoradiography film.
Student’s t-tests were used to analyze statistical significance of
SEAP transcriptional levels.
Fluorescence Microscopy
Images of live cells were collected using a Zeiss Axioscope two
plus microscope (Carl Zeiss Microscopy, LLC, Thornwood, NY,
United States) fitted with a Qimaging RetigaTM SRV charge-
coupled device digital camera (Qimaging, Surrey, BC, Canada),
i-Vision software for macintosh (Bio Vision Technologies, Exton,
PA, United States) and a Uniblitz shutter assembly (Vincent
Associates/ UNIBLITZ, Rochester, NY, United States). Pertinent
filter sets for the above applications include CZ909 (GFP),
XF114-2 (CFP), Filter set 15 (DsRed1), and 49 (DAPI and
Hoechst 33258) (Chroma Technology Group, Bellows Falls, VT,
United States). Where applicable, images were normalized using
i-vision software and pseudo-colored and adjusted using Adobe
Photoshop software (vs13.0 × 64, Adobe Systems, San Jose, CA,
United States).
Subcellular Fractionation Assay
Cells were grown in a 2% raffinose synthetic complete medium
at 25◦C until reaching mid-log phase. Then, galactose was added
to the media to a final concentration of 2% to induce Htt-
25Q-NLS-GFP or Htt-103Q-NLS-GFP expression from the GAL
promoter for 4 h at 25◦C. Whole cell extract (WCE) was purified
from 50 OD600 equivalent cells. Subcellular fractionation was
performed as described previously (Au et al., 2008). Western
blot analysis of WCE, soluble, and chromatin fraction was
carried out to monitor the Htt25Q-NLS or Htt103Q-NLS levels.
Tub2 and histone H3 were used as markers for soluble and
chromatin fractions, respectively. Protein levels were quantified
using Gene Tools software (version 3.8.8.0) from SynGene
(Frederick, MD, United States). Primary antibodies were anti-
GFP mouse (1:3000, 11814460001, Roche), anti-Tub2 rabbit
(1:3000, Basrai laboratory), and anti-H3 rabbit (1:7500, ab1791,
Abcam).
Total RNA Isolation
Cells were grown in a 2% raffinose synthetic complete medium at
25◦C until reaching mid-log phase. Then, galactose was added to
the media to a final concentration of 2% to induce Htt-25Q-NLS
or Htt103Q-NLS expression from the GAL promoter for 4 h at
25◦C. Total RNAs were isolated from 3 OD600 equivalent cells
using MasterPureTM Yeast RNA purification kit with DNase I
treatment as indicated by the manufacturer (Epicentre). All RNA
samples had an RNA integrity number (RIN) of 8 and above,
indicative of high sample quality. Half of the sample is used for
RNA sequencing, and another half is for RT-PCR for a validation
of the RNA sequencing.
Reverse Transcription-PCR (RT-PCR)
Total RNAs (100 ng for HBT1, 10 ng for UIP4 and UBC11,
and 1 ng for ACT1) were analyzed by AccessQuickTM RT-
PCR system (Promega). Primer sets and PCR conditions are
available upon request. PCR products were loaded onto Ethidium
Bromide-stained 1.5% agarose gels in TBE (KD Medical) and
band intensities were quantified with Gene Tools software
(version 3.8.8.0) from SynGene (Frederick, MD, United States).
Expression levels were calculated based on the standard curve on
the same gel and relative values were determined when level of
the NLS-Htt25Q-GFP [Vector] was defined as 100.
mRNA-Seq and Analysis
Three independent RNA-seq libraries for each of 4 samples were
prepared from total RNA using the Illumina TruSeq Stranded
Total RNA Kit RS-122-2201. They were pooled and sequenced
in a single 150 cycle paired end HiSeq run at the Frederick
National Laboratory for Cancer Research (FNLCR) at the CCR
Sequencing Facility, NCI, NIH, Frederick, MD 21701. Fifty-six
to 81 million pass-filter reads were obtained with > 95% base
calling quality of Q30. Reads were adapter-trimmed with low-
quality calls removed using Trimmomatic v0.36 and aligned
using STAR 2.5.1. The transcriptome reference was annotated
transcripts from Saccharomyces cerevisiae S288C, assembly EF4
(Ensembl). One library (YMB10544_c) contained 45% rRNA
sequences and was removed from further analysis (all other
libraries contained < 2% rRNA reads). Genewise read counts
were quantitated using RSEM 1.2.22, and differential expression
analysis was performed using edgeR version 3.20.9 utilizing the
tool’s GLM functionality. An F-like test was performed first to
identify genes showing a statistically significant difference in at
least one condition (3961 of 7126 total), and only these genes
were included in subsequent pairwise comparisons. Analysis of
identified transcripts was completed using the online Panther
classification system1 (Mi et al., 2013) and the Saccharomyces
Genome Database2.
1www.pantherdb.org
2www.yeastgenome.org
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FIGURE 1 | STUbL subunits Slx5 and Slx8 alleviate toxicity of poly-Q expanded Htt. (A) WT, slx51, and slx81 strains expressing Htt-25Q, Htt-103Q, or empty
vector (EV) were grown to mid-logarithmic phase and 5 µl of 10-fold serial dilutions of each culture were spotted on SC-URA medium. Plates were incubated at
30◦C for 3 days. (B) Yeast transformants in A and the indicated controls were grown overnight in 5 ml of SC-URA medium. Ten OD600 readings of cultures were
recorded every hour until the OD600 reached ∼2.0. The average doubling times of four independent experiments were graphed with +/– standard error. EV (empty
vector) (C) A shuffle strain, slx51 with SLX5/TRP plasmid (YOK 2990), was transformed with either Htt-25Q or Htt-103Q constructs. Transformants were patched in
duplicate on selective medium (SC-TRP URA) and rich medium (YPD). Patches were then replica plated on SC-URA medium with 5FAA to counter-select against the
TRP1 marked plasmid.
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RESULTS
Expression of Poly-Q Expanded
Huntingtin Causes a Growth Defect in
STUbL Mutants
STUbLs play an important role in the quality control of both
SUMO-modified and non-sumoylated proteins (Wang et al.,
2006; Xie et al., 2010; Westerbeck et al., 2014). Therefore, we
tested our hypothesis that Slx5 and Slx8 are required for growth
in the presence of a toxic, aggregation-prone model protein:
exon 1 of poly-Q expanded Htt. Budding yeast is established
as an exquisite model system for the study of poly-Q expanded
proteins (Krobitsch and Lindquist, 2000) and hence we compared
the effect of expression of Htt with either a 25-glutamine
residue tract (Htt-25Q or 25Q) or an abnormal, aggregation-
prone 103-glutamine tract (Htt-103Q or 103Q) on the growth
properties of WT, slx51, and slx81 cells. Isogenic WT, slx51,
and slx81 cells were transformed with low-copy (CEN) plasmids
expressing GFP-tagged Htt-25Q or Htt-103Q under control of
the constitutive GPD promoter (Krobitsch and Lindquist, 2000).
The resulting transformants, or an empty vector control, were
grown to mid-log phase and equal numbers of cells were serially
diluted and spotted on selective media (Figure 1A). Though
slx51 and slx81 cells initially formed smaller colonies than
WT cells, no severe growth defect or lethality was apparent
after 2–3 days of growth at 30◦C for both the vector and
Htt-25Q transformants (Figure 1A top and middle panel). In
contrast, slx51 and slx81 cells transformed with the Htt-103Q
construct showed a severe growth defect (Figure 1A bottom
panel), supporting our hypothesis that STUbLs are required to
relieve the growth-inhibiting properties of aggregation-prone
poly-Q expanded Htt in budding yeast.
Next, we used liquid cultures to investigate the effect of Htt-
25Q and Htt-103Q constructs on the growth of WT, slx51,
and slx81. For this analysis, we compared the slopes of growth
curves for WT, slx51, and slx81 cells that were transformed with
either Htt-25Q or Htt-103Q constructs. First, we found that WT
cells transformed with Htt-25Q or Htt-103Q grew equally well
as slx51 cells once established in logarithmic phase of growth
(Figure 1B top left). Similarly, slx51 and slx81 cells transformed
with either an empty vector or the Htt-25Q construct displayed
similar growth characteristics (Figure 1B, top right and bottom
left). In sharp contrast, the growth curves for slx51 and slx81
cells transformed with 103Q constructs revealed a significant
growth delay with two- to four-fold increases in doubling times
from 2 to 8 h (Figure 1B bottom right).
Further support that STUbL subunits, Slx5, and Slx8, have
a role in preventing the Htt-103Q induced growth delay or
toxicity was derived from a shuﬄe assay used to examine the
ability of a slx51 STUbL mutant to grow in the presence of
Htt-25Q or Htt-103Q. For this assay, a slx51 shuﬄe strain
(slx51; SLX5/TRP1/CEN) was transformed with Htt-25Q or Htt-
103Q. All transformants showed similar growth characteristics
and were patched in duplicate onto selective (-TRP -URA) media.
Once patches grew in, cells were replica-plated on rich media
(YPD) and then onto 5FAA media to counter-select against the
TRP-marked WT SLX5 plasmid (Toyn et al., 2000). After two
successive replicas onto fresh 5FAA media, the majority of cells
with the Htt-103Q construct failed to grow into colonies because
they had lost SLX5. In stark contrast, slx51 cells harboring Htt-
25Q grew unimpeded because growth of these cells did not
depend on SLX5 (Figure 1C). In summary, our results show that
STUbLs provide an essential function for yeast cells growing in
the presence of aggregation-prone, poly-Q expanded proteins.
Slx5 Reduces the Number of Poly-Q
Expanded Huntingtin Aggregates
Intrigued by the poly-Q-induced growth defect in both STUbL
mutants, we decided to compare the phenotypic manifestations
of aggregation-prone Htt in WT, slx51, and slx81 cells. We
used a fluorescence microscope to collect images of WT, slx51,
and slx81 cells transformed with either the GFP-tagged 25Q
construct or a GFP-tagged 103Q construct. We predicted, based
on the results of our growth assays (Figure 1), that STUbL
mutants would affect the localization of 103Q construct but not
the 25Q construct. Consistent with previous results (Krobitsch
and Lindquist, 2000), the Htt-25Q-GFP construct was evenly
distributed across the nucleus and cytosol of WT, slx51 and
slx81 cells (data not shown). In contrast, WT cells expressing
Htt-103Q-GFP revealed a mixture of speckles, aggregates, and
diffuse-staining cells (see Supplementary Figure S1). However,
the majority of slx51 and slx81 cells expressing 103Q did not
reveal a GFP signal as these cells were dead, as determined by a
vital stain that differentiates live and dead cells (Supplementary
Figure S1). By comparison, WT cells expressing 103Q contained
less than 5% of dead or dying cells in the culture. These
results also show that constitutive expression of 103Q, unlike
25Q, results in lethality of STUbL mutants. These data are
consistent with our growth assays (Figures 1A–C) and support
our conclusion that STUbLs fulfill an essential role in preventing
cytotoxicity due to poly-Q expanded proteins such as Htt-103Q.
The Htt-103Q-induced lethality in slx51 strain impeded
our microscopic analysis of Htt toxicity in STUbL mutants
and hence we assayed the effect of plasmid-borne SLX5 on
the phenotype of 103Q aggregates in WT cells. We reasoned
that Slx5, owing to it’s quality-control functions, may alter
the aggregation or distribution of Htt aggregates in WT cells.
WT cells were transformed with GFP-tagged 103Q and either
a SLX5 CEN plasmid (under control of its own promoter
on a low-copy CEN vector) or an empty control vector. The
transformants were grown to mid-logarithmic phase in selective
media and 103Q aggregates were analyzed using fluorescence
microscopy (Figure 2A). We determined that the incidence of
103Q aggregates was reduced by almost 14-fold while the number
of diffuse-staining cells increased by at least twofold with plasmid
borne SLX5 (Figure 2B).
Htt has been reported to reside both in the cytosol as well
as the nucleus, but the majority of Htt aggregates are observed
to form in the cytosol (Davies et al., 1997; Krobitsch and
Lindquist, 2000). The nuclear localization of Slx5 and Slx8
(Cook et al., 2009) and the lethality of Htt103Q in slx51
and slx81 strains prompted us to further investigate the role
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FIGURE 2 | Plasmid-borne SLX5 reduces aggregates of poly-Q expanded
huntingtin. (A) Representative images of Htt-103Q in WT cells with and
without an SLX5/CEN plasmid. Example of aggregates (clearly defined, bright
cytoplasmic structures – red arrow-heads) and speckles (multiple small, not
clearly defined cytoplasmic granules – blue arrow-heads) (B) Quantitation of
phenotypes observed in 2A. WT strain expressing Htt-103Q-GFP alone (YOK
2842) or Htt-103Q-GFP with SLX5 (YOK 2843) were grown to mid-logarithmic
phase in selective medium. Images of 103Q diffuse staining, aggregates, and
speckles in the indicated strains were recorded and then quantitated.
Average counts for three independent experiments were graphed +/– standard
(Continued)
FIGURE 2 | Continued
deviation. Y-axis: percent of cells (n = 100/experiment). Y-axis: phenotypes
scored (C) Aggregates of poly-Q expanded Htt are localized in the cytoplasm.
WT and slx51 strains transformed with GAL-Htt-97Q-DsRed (YOK 3112 and
YOK 3114) were grown overnight in SC-TRP medium with 2% raffinose.
Cultures were diluted to ∼0.2 OD in a fresh medium with 2% galactose and
incubated for an additional 16 h for expression of Htt-97Q-DsRed prior to
imaging Htt aggregates using a fluorescence microscope. Nuclei were stained
with Hoechst dye. Merged images indicate the absence of Htt-97Q
aggregates in nuclei (yellow arrow-heads).
of STUbLs in the localization of Htt. For this analysis, we
transiently expressed 97Q-DsRed under control of the strong
inducible GAL promoter in WT and the slx51 mutant. This
transient expression prevented the cytotoxicity associated with
constitutive expression of aggregation-prone Htt in slx51 strains.
After galactose induction, we imaged the nuclei of live WT and
slx51 cells were stained with Hoechst dye (33342). In both
WT and slx51 cells (n > 200), Htt aggregates or speckles were
solely observed in the cytosol. A low level of diffusely staining
97Q-DsRed was evenly distributed between the cytosol and the
nucleus of WT and did not appear to be enriched in either
compartment. A similar localization pattern for 97Q-DsRed to
that in WT cells was observed in the slx51 cells (Figure 2C).
Based on these results we propose that 97Q, under the conditions
employed, does not readily form large aggregates in the nuclei of
yeast cells.
Regulation of Transcriptional Activity of
Htt by Slx5 and RNF4
It was previously reported that poly-Q expanded Htt, in the
absence of a Gal4-DNA-binding fusion (BD), induces the
expression of reporter genes in a two-hybrid reporter assay
(Atanesyan et al., 2012). This transcriptional auto-activation was
directly related to the length of the poly-glutamine tract in Htt
(Atanesyan et al., 2012). Therefore, we determined the effect of
Slx5 on this poly-Q dependent transcriptional activity. Htt-25Q
and Htt-55Q were fused to the Gal4 activation domain (AD) and
assayed for the auto-activation of each construct in the presence
or absence of BD-Slx5 or just BD. Consistent with published data
(Atanesyan et al., 2012), all AD fusions of Htt, by themselves,
induced expression of both a HIS3 and a lacZ reporter gene,
indicating that both 25Q and 55Q associate with the Gal4-UAS
independent of a BD (Figure 3A). We used AD-Htt-25Q and
AD-Htt-55Q to avoid the potential toxicity associated with AD-
Htt-97Q. Auto-activation of the HIS3 reporter gene was scored
using a growth assay, transformed cells where diluted and spotted
on media with (SD-Trp-Leu) or without histidine (SD-Trp-
Leu-His). Concomitantly, auto-activation of the lacZ reporter
was quantitated using ONPG assays that were performed in
triplicate. Intriguingly, when the AD-Htt constructs were paired
with BD-Slx5, the Htt-induced auto-activation was reduced to
background levels (Figure 3A). To confirm that the reduction of
the Htt-induced transcriptional auto-activation is not due to the
decreased expression of Htt 25Q and Htt 55Q in the presence of
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FIGURE 3 | The STUbL subunit Slx5 reduces the transcriptional auto-activation of poly-Q expanded Htt. (A) Yeast two-hybrid strain pJ694α was co-transformed
with the indicated AD and BD plasmids. 1 OD of overnight-grown cells were diluted 100-fold and 5 µl of each cell suspension was spotted on SC-TRP LEU
for growth control and SC-TRP LEU HIS to assess activation of the HIS3 reporter gene. Transcriptional activation was also scored by quantification of β-galactosidase
(Continued)
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FIGURE 3 | Continued
activity using ONPG assays (error bar – SD). (B) Effect of Slx5sim expression on the repression of poly-Q expanded Htt auto-activation as indicated by growth on
SC-TRP LEU HIS medium and β-galactosidase assays. (C) Expression of the human SLX5 ortholog RNF4 represses the transcriptional activity of poly-Q expanded
Htt. To assess activation of the lacZ reporter gene in the indicated strains β-galactosidase units of strains were determined and graphed +/– standard deviation.
(D) RNF4 significantly reduces the transcriptional activation of Htt in mammalian cells. Mammalian two hybrid analysis of PC3, LNCaP, HEK 293, PNT2, and PC12
cells [n = 3]. Reporter gene auto-activation of 25Q and 55Q Htt was assessed by transfection of pM-EV (empty vector) and pVP16-Htt. Where indicated, pM-RNF4
was cotransfected with 25Q or 55Q Htt to measure RNF4’s inhibitory function. Values of relative SEAP luminescence for 55Q are graphed as shown and values for
both 25Q and 55Q are shown in the table below the graph. Assay results were normalized to the positive control. Error bars represent standard deviation.
∗∗p < 0.01, ∗∗∗p < 0.001.
BD-SLX5, we tested the expression of AD-Htt 25Q and AD-Htt-
55Q by Western blotting (Supplementary Figure S3). The result
shows that the steady state levels of both Htt-25Q and Htt-55Q
were not affected by BD-SLX5.
Next we asked if the suppression of AD-Htt reporter gene
activation was dependent on the SIMs in Slx5. We combined
a SIM mutant of Slx5 that fails to interact with SUMO (BD-
Slx5sim) with AD-55Q and assessed the auto-activation properties
of our poly-Q Htt constructs on the two reporters using growth
and quantitative ONPG assays. We found that Slx5sim reduced
the auto-activation of the AD-55Q construct significantly less
than WT Slx5 (Figure 3B, ONPG assay). This data suggests that
SUMO-binding may support the ability of Slx5 to suppress the
transcriptional activity of AD-Htt. However, SUMO-binding of
Slx5 may not be a steadfast requirement to reduce Htt toxicity
because the Slx5sim mutant can still suppress the Htt-103Q
growth phenotype (Supplementary Figure S2).
To determine whether ability of Slx5 to repress auto-activation
of poly-Q expanded Htt is evolutionarily conserved, we tested
mammalian BD-RNF4 in combination with AD-25Q and AD-
55Q. Consistent with results for Slx5, RNF4 also repressed the
auto-activation activity of AD-25Q and AD-55Q constructs in
our reporter assay (Figure 3C). In the presence of RNF4, the
auto-activation activity of AD-25Q and AD-55Q was reduced
threefold, when compared to AD-55Q alone. These results
strongly support a role for RNF4, and other STUbLs, in
counteracting the aggregation of transcriptionally active Htt
and possibly other poly-Q expanded proteins associated with
neurodegenerative diseases.
Finally, we tested whether RNF4 curbs the transcriptional
activity of aggregation-prone proteins in a mammalian tissue
culture model of Huntington’s disease, employing a mammalian
Matchmaker (2-hybrid) assay. For this approach, both Htt-25Q
and Htt-55Q were cloned into the pVP16AD Gal4-activation
domain vector and co-transformed with the reporter plasmid
pG5SEAP into 5 separate cell lines (PC3, LNCaP, HEK293, PNT2,
and PC12). Consistent with our finding in yeast, all mammalian
cell lines recapitulated the Htt-dependent transcription of the
pG5SEAP reporter (Figure 3D – blue bars). Next, reporter gene
activation was assayed in the presence of BD-RNF4. Mammalian
two-hybrid analysis in all cell lines displayed a significant
decrease in the transcriptional activation of 25Q and 55Q Htt
upon addition of RNF4 BD (Figure 3D green bars and table).
The strength of RNF4’s inhibitory effect ranged from 30–60%
reduction on 25Q but was statistically significant for all 5 cell
lines (Student’s T-test), indicating that RNF4’s inhibitory effect
is consistent and reproducible. In all cell lines, 55Q mHtt
displayed greater transcriptional reduction (40–70%), suggesting
that this poly-Q expanded 55Q Htt is more amenable to RNF4’s
activity. Due to their neuronal origin, results from the PC12
cell two-hybrid are the most physiologically relevant model of
Huntington’s Disease. As an important indicator of specificity,
reporter gene activation by a positive control construct (pM-
pVP16), was not affected by transfection of RNF4 (data not
shown). In summary, we have now shown that both in yeast
and mammalian cells auto-activation of Htt can be significantly
modulated due to the activity of STUbLs.
Slx5 Reduces Chromatin-Associated Htt
Aggregates in Budding Yeast
To study the physiological relevance of our assays for
transcriptional activity, we examined whether Htt-103Q
associates with chromatin using subcellular fractionation of
whole-cell lysates after overexpression of nuclear targeted
Htt-25Q-NLS-GFP or Htt-103Q-NLS-GFP. We assayed levels
of Htt in whole-cell extracts, soluble fractions, and chromatin
(Figure 4A). As expected, both aggregated (high-molecular
weight) and non-aggregated (53 kD, monomer) forms of Htt-
103Q, but not Htt-25Q, were clearly detectable in the chromatin
fraction, indicating that both aggregated and non-aggregated
Htt-103Q associate with chromatin.
To examine the role of SLX5 in modulating chromatin
bound Htt-103Q, we assayed levels of Htt-103Q-NLS-GFP in
the presence or absence of plasmid-borne SLX5 (Figures 4B–E).
Consistent with the microscopy of Htt-103Q-GFP expressing
cells (Figure 2B), the soluble, monomeric form of Htt-103Q
(53 kDa) was increased with plasmid-borne SLX5 (Figures 4B,C).
Importantly, aggregated Htt in the chromatin fraction was
reduced ∼3-fold (p = 0.0262) in the strain with plasmid borne
SLX5 (Figures 4B,D). In contrast, monomeric, chromatin-
bound Htt-103Q (53 kDa) remained similar in both strains
(Figures 4B,E). These data show that increased expression of
SLX5 specifically reduces Htt-103Q aggregates in chromatin.
We propose that STUbLs contribute to reducing chromatin-
associated Htt aggregates.
Identification of Htt-Altered Transcripts
Modulated by a STUbL in Yeast
The reduced association of aggregated Htt-103Q-NLS with
chromatin in the presence of plasmid-borne SLX5 (Figure 4B)
led us to postulate that Slx5 curbs the abnormal transcriptional
activities induced by Htt-103Q-NLS. Hence, we performed
genome-wide RNA-seq analysis to examine the transcriptome
Frontiers in Genetics | www.frontiersin.org 9 September 2018 | Volume 9 | Article 379
fgene-09-00379 September 18, 2018 Time: 12:9 # 10
Ohkuni et al. STUbLs Regulate Huntingtin’s Transcriptional Activity
FIGURE 4 | Slx5 reduces the level of chromatin associated Htt103Q aggregates. (A) Htt103Q, but not Htt25Q, associates with chromatin. Whole cell extracts
(WCEs) prepared from equal numbers of cells expressing GFP-tagged Htt25Q-NLS or Htt103Q-NLS from a GAL promoter were fractionated into soluble and
chromatin fractions. Htt25Q-NLS-GFP or Htt103Q-NLS-GFP levels in each fraction were monitored by western blot analysis with anti-GFP antibody. Tub2 and
(Continued)
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FIGURE 4 | Continued
histone H3 were used as markers for soluble and chromatin fractions, respectively. (B) WCEs prepared from equal numbers of cells expressing Htt103Q-NLS-GFP
with (SLX5-CEN) or without (Vector) were fractionated into soluble and chromatin fractions as described in A. Htt103Q-NLS-GFP levels were monitored by western
blot analysis with anti-GFP antibody. Three independent transformants were assayed and shown are the results from two of these. (C) Quantification of the 53 kD
GFP signals in soluble fraction from 4B. The 53 kD GFP was normalized using Tub2 levels in soluble fraction. The graph represents the mean of three independent
clones with SEM. P-value is 0.0317. (D) Quantification of the aggregate GFP signals in chromatin fraction from 4B. The aggregate GFP signal was normalized using
H3 levels in chromatin fraction. The graph represents the mean of three independent transformants with SEM. P-value is 0.0262. (E) Quantification of the 53 kD GFP
signals in chromatin fraction from 4B. The 53 kD GFP (shorter exposure) was normalized using H3 levels in chromatin fraction. The graph represents the mean of
three independent transformants with SEM. P-value is 0.3523.
of four strains expressing either Htt-25Q-NLS or Htt-103Q-NLS
with or without plasmid-borne SLX5. Consistent with the effect
of Htt-103Q on transcription, our results showed that the
expression of > 50% of all yeast genes (3438 genes) was altered
in the presence of Htt-103Q-NLS when compared to Htt-25Q-
NLS with empty vector (Figure 5A, 25Q [V] vs. 103Q [V]). Of
the 3438 genes affected by Htt-103Q-NLS, 48.6% of the genes
were up-regulated and 51.4% were down-regulated. These results
show that chromatin associated Htt-103Q-NLS affects global
transcription in budding yeast.
We next analyzed the effect of plasmid-borne SLX5 on the
transcriptome of cells expressing Htt-25Q-NLS or Htt-103Q-
NLS. Our RNA-seq data showed that SLX5 had a minimal
effect on the transcriptome of cells expressing Htt-25Q-NLS as
only 33 genes were differentially expressed (25Q [V] vs. 25Q
[SLX5]). In contrast to this, plasmid-borne SLX5 affected the
transcription of 398 genes in cells expressing Htt-103Q-NLS
when compared to Htt-103Q-NLS without SLX5 (Figure 5A,
103Q [V] vs. 103Q [SLX5]). The majority of the 398 genes
encode for proteins that reside in the cytoplasm (37%), nucleus
(19%), or mitochondria (14%) (Figure 5B and Supplementary
Table S4). Of the 398 genes that were significantly altered
by plasmid-borne SLX5, 66% (261) genes were upregulated
and 34% (137) genes were down-regulated (Supplementary
Table S2). We observed two distinctive characteristics on the
transcriptome of Htt-103Q-NLS with and without plasmid-
borne SLX5 (Figure 5C). First, for 99.4% (361 out of 363)
of SLX5-affected genes, the effect of added Slx5 was inversely
correlated with that of 103Q (Supplementary Table S2 and
Figure 5A). Plasmid-borne SLX5 upregulated the expression
of 68.0% (247) of the genes that were downregulated by Htt-
103Q-NLS, and downregulated the expression of 31.4% (114)
of genes that were upregulated by Htt-103Q-NLS (Figure 5A).
For example, expression of YAL008W was down-regulated by
Htt-103Q-NLS, and up-regulated by plasmid-borne SLX5. In
contrast, expression of YAL014C was up-regulated by Htt-
103Q-NLS, and down-regulated by plasmid-borne SLX5. Only
two genes (YDL182W and YGR092W) were an exception to
this pattern (Supplementary Table S2). A second distinctive
characteristic of the transcription profiles show that about
25% of the genes that are affected by plasmid-borne SLX5
are neighbors or adjacent to each other on the chromosome
(e.g., YBR052C, YBR053C, and YBR054W) (Supplementary
Table S3). The RNA sequencing data generated in this study have
been deposited in NCBI’s Gene Expression Omnibus (Barrett
et al., 2013) and are accessible through GEO Series accession
number GSE115990.
To confirm the transcriptome data from RNA-seq, we
performed RT-PCR to assay the transcription of a subset of
Htt-103Q-NLS/Slx5 modulated genes such as YDL223C/HBT1,
YPL186C/UIP4, and YOR339C/UBC11 (Figure 5D). Consistent
with our RNA-seq data, we found that expression of
YDL223C/HBT1 and YPL186C/UIP4 is down-regulated by
Htt-103Q-NLS, and up-regulated by plasmid-borne SLX5
(Down-Up). In contrast, YOR339C/UBC11 is up-regulated by
Htt-103Q-NLS, and down-regulated by plasmid-borne SLX5
(Up-Down). In agreement with the RNA-seq data the expression
of ACT1 was not significantly affected when assayed by RT-PCR.
In summary, our data shows that chromatin-associated Htt-
103Q-NLS affects global transcriptional in budding yeast. Most
importantly, we define a role for Slx5 in modulating the aberrant
transcriptional activity, induced by chromatin-associated
Htt-103Q-NLS.
DISCUSSION
In this study we show, for the first time, that STUbLs are required
to prevent the toxicity associated with an aggregation-prone
protein namely poly-Q expanded Htt and define a functional
role for STUbLs in counteracting the toxic effects of Htt-
103Q expression. Using reporter gene assays we determined that
Slx5 and RNF4 reduce the transcriptional activity of Htt in
yeast and human cells, respectively. For example, Htt fused to
the Gal4 activation domain (AD) auto-activates Gal4-regulated
reporter genes. However, reporter gene activation by Htt-AD
is reduced to background levels in the presence of BD-Slx5 or
BD-RNF4. Most importantly, our results show that Slx5 reduces
cytosolic and chromatin-associated Htt-103Q aggregates and
modulates the transcriptome of cells expressing Htt-103Q. Taken
together we provide evidence for a conserved role of STUbLs
in preventing the accumulation of aggregating proteins such
as Htt on chromatin and propose that STUbLs counteract the
transcriptional effect of these aggregates in yeast and mammalian
cells.
In the initial stages of our analysis of Htt in STUbL mutants,
we focused on the cellular distribution and aggregates formed
by aggregation-prone Htt in yeast. We detected aggregates,
speckles, and diffuse-staining Htt in both WT and a yeast STUbL
mutant, slx51 (Supplementary Figure S1). Due to its toxicity
in STUbL mutants, we ultimately studied the effect of an extra
plasmid-borne copy of SLX5 in WT cells expressing Htt-103Q.
Presence of the SLX5 plasmids increased diffusely staining Htt
in WT cells while reducing the incidence of Htt aggregates
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FIGURE 5 | Slx5 modulates the transcriptional activity due to expression of Htt-103Q-NLS. Depiction of 398 SLX5 modulated genes identified by RNA sequencing.
(A) RNA-seq analysis shows that Htt103Q-NLS leads to a global effect on the transcriptome as it affects the expression of 3438 genes (25Q [V] vs. 103Q [V]).
Plasmid-borne SLX5 affects the expression of 398 genes in Htt103Q-NLS cells (103Q [V] vs. 103Q [SLX5]) as shown in Supplementary Table S2. The overlap
(Continued)
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FIGURE 5 | Continued
between Htt25Q-NLS and Htt103Q-NLS (25Q [V] vs. 103Q [V]) is 363 genes. The expanded view of A shows that expression of most of the 363 genes (99.4%)
inversely correlates between 25Q [V] vs. 103Q [V] and 103Q [V] vs. 103Q [SLX5]. Expression of 247 of the 363 genes (68.0%) is down-regulated by Htt103Q, and
this effect is reversed by plasmid-borne SLX5 (Down – Up). Expression of 114 of the 363 genes (31.4%) is up-regulated by the Htt103Q, and this effect is reversed
by plasmid-borne SLX5 (Up – Down). (B) Subcellular localization of differentially expressed genes. The localization of proteins encoded by the 398 genes indicated in
Supplementary Table S2 was analyzed using cellular components assignment from the PANTHER Classification System and the Saccharomyces Genome
Database. Pie chart shows a ratio of the genes placed into cellular component categories. Individual genes are listed in Supplementary Table S4. (C) Schematic of
gene expression in Htt25Q-NLS and Htt103Q-NLS cells and the effect of plasmid-borne SLX5 on the transcriptome of Htt103Q-NLS cells. Expression of genes A
and B are downregulated and upregulated in Htt103Q-NLS cells relative to Htt25Q-NLS cells, respectively. Slx5 reduces the association of Htt with chromatin and
this contributes to the reversal in gene expression such that gene A is upregulated and gene B is downregulated. (D) RT-PCR validation of gene expression analysis.
Total RNAs were purified from strains expressing either Htt25Q-NLS or Htt103Q-NLS from a GAL promoter for 4 h with or without plasmid-borne SLX5. RT-PCR
analyses was performed using the same samples used for the RNA-seq. Relative intensities are reported as the mean ± SD of three biological repeats. Reactions for
YDL223C/HBT1 and YPL186C/UIP4 were performed in duplicate. N = 3 for YOR339C/UBC11 and YFL039C/ACT1, N = 6 for YDL223C/HBT1 and YPL186C/UIP4.
(Figures 2A,B). However, we failed to detect a reproducible,
STUbL-dependent, reduction of Htt by western blot analysis
(for example Supplementary Figure S3). Previously it has been
reported that the STUbL RNF4 is involved in the degradation
of another poly-Q expanded protein, Atxn1 82Q (Guo et al.,
2014). While our data are consistent with a re-distribution of
Htt aggregate, we did not observe that Slx5 altered the steady-
state levels of this aggregation-prone protein. One explanation
for this may be that budding yeast cells do not disassemble
the nuclear envelope, making it difficult to observe the effect of
nuclear localized STUbLs on aggregates of Htt in the cytosol. We
overcame this limitation in our yeast model by using nuclear-
targeted Htt-103Q to assess both the transcriptional activity and
the chromatin association of Htt in the presence or absence of
SLX5 (Figure 3 and Figure 4).
First, using Gal4-based two-hybrid reporter assays, we were
able to show that yeast Slx5 and human RNF4, both nuclear
localized proteins, curb the transcriptional activity of Htt.
Therefore, we predict that the role of RNF4 in mammalian
cells is to dispel transcriptionally active Htt complexes rather
than to degrade cytosolic Htt aggregates. However, at this point
we cannot entirely exclude the possibility that Slx5 and RNF4
form repressive promotor-associated complexes see (Cubeñas-
Potts and Matunis, 2013). Regarding the Gal4-AD-fusion of
Htt, similar constructs have proven invaluable in defining the
aberrant transcriptional activity of poly-Q expanded proteins.
The most important observation in this regard is that the poly-
Q domain is necessary and sufficient for both the targeting to the
Gal4 UAS and reporter gene activation (Atanesyan et al., 2012).
Furthermore, introduction of a poly-Q stretch into transcription
factors increases their transcriptional activity. Even though we
have not yet observed a direct, physical interaction between
Htt and Slx5 (we predict a transient interaction involving Htt-
associated proteins), our assays are consistent with an important
role of Slx5 in counteracting nuclear activities of aggregation
prone, chromatin associated proteins. The finding that a STUbL
plays an important role in transcriptional regulation is not
entirely surprising. Before it became known as a STUbL, RNF4
had already been identified as a co-regulator of androgen
receptor-dependent transcription (Yan et al., 2002). Furthermore,
RNF4 can act both as a transcriptional activator or a repressor
depending on the proteins it interacts with (Fedele et al., 2000).
Second, using Gal-driven, nuclear-targeted 103Q constructs,
we assessed the chromatin association of an aggregation-prone
Htt construct. This time we were able to clearly document
that an extra plasmid-borne copy of SLX5 reduced the levels
of chromatin-associated Htt (Figure 4). The association of
Htt with DNA, transcription factor recognition elements, and
transcription factors has previously been reported (Benn et al.,
2008). STUbLs may provide a mechanism to counteract these
inappropriate associations of Htt. For example, it is tempting
to speculate that Slx5 recruits Cdc48/Ufd1/Npl4 (Cdc48-UN), a
SUMO-targeted STUbL effector, to dislodge Htt from chromatin
(Nie et al., 2012; Bergink et al., 2013). Cdc48 has also been
identified in association with Htt aggregates and we are now
studying the effect that Cdc48-UN plays in Htt-mediated
transcriptional activation (Wang et al., 2008).
Finally, we have completed a global RNA sequencing study
to identify those transcripts that are affected by nuclear-targeted
Htt-103Q and modulated by an extra plasmid-borne copy of
SLX5. Our transcriptome analysis revealed that SLX5 counteracts
transcriptional abnormalities of 398 genes induced by expression
of 103Q-NLS. Dysregulated transcripts encode proteins localized
throughout the cells, with the majority enriched in the
cytoplasm (263) nucleus (33) and mitochondria (19). Functional
categorization of the differentially transcribed genes showed
that at least 22 are involved in transcription, transcriptional
regulation, and RNA/DNA binding (RTC3, RPA43, RPB7,
BUD27, TFA2, SRB7, YAP7, MCM1, PHO4, MAP1, HSP31, SNF5,
RPP1, TMA22, RPS27A, MRPL49, NHP2, RPL7A, RPL7B, MAP1,
HST2, and CBC2) (Supplementary Table S4). We posit that
some of the transcriptionally active and chromatin-associated
proteins identified in our study represent genuine STUbL
targets. Additionally, several SLX5-modulated genes identified
here have previously been described in other Htt studies [e.g.,
Glo2 (human HAGH1), ZTA1 (human zeta crystalline), Msb1,
COA2, BUD22, ERG5, and TIR1], supporting a genuine role
of STUbLs in counteracting huntingtin-mediated dysregulation
(Willingham et al., 2003; Wolfe et al., 2014). We prefer a model
in which Htt aggregates may contain both sumoylated and
non-sumoylated proteins, including those listed above. STUbL-
mediated ubiquitination could then result in the recruitment
of the Cdc48-UN desegregase and the subsequent proteasomal
degradation of ubiquitylated proteins in the aggregates (reviewed
in Kerscher, 2016).
In summary, the STUbL/Htt assay is one of the first of its
kind to assess the ability of RNF4 and other STUbLs to modulate
the activity of transcriptionally active, aggregation-prone
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proteins. This reporter assay should complement other
sophisticated genetic tools used to study protein aggregation
processes (Newby et al., 2017). Results from our reporter assays
are consistent with biochemical and genome-wide transcriptome
data and provide evidence for a role of STUbLs in preventing
toxicity due to aggregation-prone Htt in the nucleus. Overall,
our findings indicate that STUbLs can reduce the chromatin
association and abnormal transcriptionally activity of Htt (or
other aggregating proteins) and suggest that mammalian STUbLs
may play neuroprotective functions in Huntington’s Disease.
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FIGURE S1 | WT strain expressing Htt-103Q-GFP alone (YOK 2842) or
Htt-103Q-GFP together with SLX5 (YOK 2843) were grown to mid-logarithmic
phase in selective medium. Images of yeast cells with diffuse staining 103Q-GFP,
aggregates, and speckles were recorded, counted, and graphed. Additionally, we
stained cells with the LIVE/DEAD Yeast Viability Kit (Thermo Fisher) to quantitate
dead or dying cells in the culture (dead). Average counts for three independent
experiments were graphed +/− standard deviation. Y-axis: percent of cells.
FIGURE S2 | The slx5SIM mutant suppresses lethality of Htt-103Q in slx51. slx51
strain YOK821 expressing 103Q-Htt/URA3 was transformed with SLX5 plasmid
(BOK376), slx5SIM mutant (BOK463), and an empty vector (pRS425). Resulting
transformants were struck to appropriate selective media and incubated for
3 days at 30◦C.
FIGURE S3 | Steady-state protein levels of AD-25Q and AD-55Q are not grossly
affected by expression of BD-Slx5. AD-25Q and AD-55Q were expressed in the
presence or absence of BD-Slx5 in the yeast two-hybrid reporter strain. Proteins
were extracted, separated by SDS–PAGE and western blotted with an antibody to
the Gal4-AD or PGK, a loading control (Szymanski and Kerscher, 2013). EV –
empty Gal4-AD vector expressing only Gal4-AD.
TABLE S1 | Strains used in this study.
TABLE S2 | Expression profiles of 398 genes regulated by an extra copy of SLX5.
An extra copy of SLX5 alters the expression profiles of 398 genes in the Htt103Q
background (Htt103Q-NLS [Vector] vs. Htt103Q-NLS [SLX5]). 363 out of these
398 genes are also found to be differently expressed between Htt25Q-NLS and
Htt103Q-NLS (Htt25Q[Vector] vs. Htt103Q[Vector]). Expression of most of the 363
genes (99.4%) is inversely correlation between Htt25Q [Vector] vs. Htt103Q
[Vector] and Htt103Q [Vector] vs. Htt103Q [SLX5]. Only two genes do not exhibit
this inverse relationship (Exceptions: YDL182W and YGR092W). Up- and
down-regulated transcripts are shown in red and blue, respectively. Green shows
35 genes that are not detected the comparison between Htt-25Q and Htt-103Q
(Htt25Q [Vector] vs. Htt103Q [Vector]).
TABLE S3 | List of clustering genes. The 398 genes, differently expressed
between Htt103Q [Vector] and Htt103Q [SLX5], are analyzed. We used systematic
name to search the neighboring genes. Up- and down-regulated profiles are
shown in red and blue, respectively.
TABLE S4 | Cellular Components Categories of genes modulated by Slx5. The
number of individual genes placed into cellular component categories is listed in
the table. Individual genes are colored red (increased expression in cells with
Htt103Q-NLS and Slx5) or blue (decreased expression in cells with Htt103Q-NLS
and Slx5), black (only one data-point – compare Supplementary Table S2). Note
that some genes analyzed are part of multiple cellular component categories.
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